Skip to main content
David Leitenberg, MD, Pathology, Washington, DC

DavidLeitenbergMD

Pathology Washington, DC

Anatomic Pathology, Clinical Pathology

Assoc Prof Microbiology, Immunology and Tropical Medicine, G Washington University School of Medicine & Hlth Sci

Dr. Leitenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leitenberg's full profile

Already have an account?

  • Office

    111 Michigan Ave Nw
    Washington, DC 20010
    Phone+1 202-884-5000

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1990 - 1992
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
  • University of Iowa
    University of IowaPh.D., 1990
  • University of Vermont
    University of VermontB.A., 1983

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2001 - 2024
  • CT State Medical License
    CT State Medical License 1993 - 2001
  • American Board of Pathology Clinical Pathology

Awards, Honors, & Recognition

  • Commendation for teaching excellence and innovation Committee on Undergraduate Medical Education, 2013
  • Recipient, Golden Apple Award for Teaching Excellence AMSA, 2011
  • Nominated for Graduate Advisor of the Year Columbian College Arts and Sciences, 2007
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent  
    Clarridge, K., D. Leitenberg, B. Loechelt, C. Picard, M. Keller, J Clinical Immunol, 1/1/2016
  • HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications  
    Karabekian Z, Ding H, Stybayeva G, Ivanova I, Muselimyan N, Haque A, Toma I, Posnack NG, Revzin A, Leitenberg D, Laflamme MA, Sarvazyan N, Tissue Eng, 1/1/2015
  • Ganglioside-treated dendritic cells inhibit T cell effector function by promoting regulatory T cell activity  
    Falahati, R., E. Mari, A. Jales, E.J. Stemy, W. Shen, C. Southammokasone, D. Herzog, S. Ladisch, D. Leitenberg, Immunology, 1/1/2011
  • Join now to see all

Books/Book Chapters

Lectures

  • Tumor Immunology for PhD and MS level students 
    Multiple Locations, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019 - 1/1/2019
  • Clinical Flow Cytometry 
    Georgetown University, 2018, 2019 - 1/1/2019
  • Hypersensitivity Responses 
    Georgetown University, 2018, 2019 - 1/1/2019
  • Join now to see all

Grant Support

  • CD45 Regulation Of T Lymphocyte ActivationNational Institute Of Allergy And Infectious Diseases2001–2003
  • CD45 Regulation Of T Lymphocyte ActivationNational Institute Of Allergy And Infectious Diseases1999–2000
  • CD45 Isoform Regulation Of T Cell ActivationNational Institute Of Allergy And Infectious Diseases1995–1997